Who Can Participate 

Participants in the MMyrelis clinical research study must: 

Be 18 years old or older
Have been diagnosed with Multiple Myeloma 
Have recently started treatment for Multiple Myeloma with teclistamab 
*Please note that there are other requirements to be eligible for this study.
If you wish to take part in this clinical research study, you can complete the pre-screening questionnaire below to see if you may be eligible to participate.

Pre-Screener Questionnaire 

Welcome to the MMyrelis clinical research study pre-screener questionnaire. Please visit ClinLife, a global web-based platform that connects patients and trial volunteers to relevant and available research trials. By clicking the link below, you will be leaving this website. 

If your answers indicate that you may join the study, you will be able to enter your address to find a study site near you. Answering the questions in the pre-screener questionnaire does not mean that you have to join the MMyrelis clinical research study.

Takeda Pharmaceutical
300 Massachusetts
Ave
Cambridge, MA 02139
Protocol Number: TAK-339-3001 

Copyright © 2025 Takeda Pharmaceutical. All rights reserved.

Useful Links

Site Links

Protocol Number: TAK-339-3001 

Copyright © 2025 Takeda Pharmaceutical. All rights reserved.
en_USEnglish
en_USEnglish
This button will link to Clinlife pre-screener once ready.

Based on the answers you have given, you may not be eligible to take part in 
[Study name]. Please speak with your doctor if you have any questions 
about your treatment options.

Based on the answers you have given, you may be eligible to take part in [Study name]. Please visit ClinLife, a global web-based platform that connects patients and study volunteers to relevant and available research studies.

By clicking the link below, you will be leaving this website.

Site Finder